Helen Sabzevari

CIK 1724195 · President and CEO · last filed 2026-06-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.77M

Companies

3

Total Filings

52

Lifetime Open-Market Net

-$4.85M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PGEN President and CEO 3,768,872 $4.45 $16.77M -$4.49M 35 2026-06-01
Kinnate Biopharma Inc. (KNTE) Delisted Director $2.65 $0 3 2023-06-13
PRECIGEN, INC. (XON) Delisted President and CEO 104,734 -$366.3K 13 2020-01-07

Recent Filings · Page 2 of 6

52 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-05-31 PGEN Grant (A) $0 EDGAR
2024-04-09 PGEN Mixed +661,072 -$574.5K EDGAR
2024-04-05 Disp (D) $0
2023-08-25 PGEN Mixed +64,618 -$117.8K EDGAR
2023-08-18 PGEN Mixed +85,732 -$92.7K EDGAR
2023-08-11 PGEN Mixed +100,151 -$59.7K EDGAR
2023-08-04 PGEN Mixed +88,717 -$58.2K EDGAR
2023-06-13 Kinnate Biopharma Inc. (KNTE) Delisted Grant (A) $0 EDGAR
2023-05-02 PGEN Grant (A) $0 EDGAR
2023-03-28 PGEN Mixed +283,173 $0 EDGAR
Showing 1120 of 52
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.